Skip to main content
Download PDF

Risk factors associated with influenza A (H1N1)pdm09: a nested case control study of TB patients with ILI in Lahore District, Pakistan

BMC Infectious Diseases volume 24, Article number: 741 (2024) Cite this article

Abstract

Background

Co-morbidity with respiratory viruses including influenza A, cause varying degree of morbidity especially in TB patients compared to general population. This study estimates the risk factors associated with influenza A (H1N1)pdm09 in TB patients with ILI.

Methods

A cohort of tuberculosis (TB) patients who were admitted to and enrolled in a TB Directly Observed Therapy Program (DOTs) in tertiary care hospitals of Lahore (Mayo Hospital and Infectious Disease Hospital) were followed for 12 weeks. At the start of study period, to record influenza-like illness (ILI), a symptom card was provided to all the participants. Every participant was contacted once a week, in person. When the symptoms were reported by the participant, a throat swab was taken for the detection of influenza A (H1N1)pdm09. A nested case control study was conducted and TB patients with ILI diagnosed with influenza A (H1N1)pdm09 by conventional RT-PCR were selected as cases, while those who tested negative by conventional RT-PCR were enrolled as controls. All cases and controls in the study were interviewed face-to-face in the local language. Epidemiological data about potential risk factors were collected on a predesigned questionnaire. Logistic analysis was conducted to identify associated risk factors in TB patients with ILI.

Results

From the main cohort of TB patients (n = 152) who were followed during the study period, 59 (39%) developed ILI symptoms; of them, 39 tested positive for influenza A (H1N1)pdm09, while 20 were detected negative for influenza A (H1N1)pdm09. In univariable analysis, four factors were identified as risk factors (p < 0.05). The final multivariable model identified one risk factor (sharing of towels, P = 0.008)) and one protective factor (wearing a face mask, p = < 0.001)) for influenza A (H1N1)pdm09 infection.

Conclusion

The current study identified the risk factors of influenza A (H1N1)pdm09 infection among TB patients with ILI.

Peer Review reports

Introduction

Influenza and other respiratory viruses pose a threat to the health of the entire world’s population as they are a major cause of disease and mortality each year [1]. The influenza viruses (A and B) are among the major pathogens causing recurrent human epidemics. Influenza A has a greater impact on public health than influenza B due to its rapid evolution and wide range of hosts [2, 3]. According to the data from the Global Burden of Disease study, the mortality rate from lower respiratory tract infections caused by influenza in the WHO Middle East and North Africa (MENA) region reached 0.9 per 100,000 population, with hospitalization rates ranging from 100 to 299 per 100,000 population [4].

Pakistan is the world’s sixth-most populous country, with 40% of its population living in cities with limited healthcare facilities, making it vulnerable to an influenza outbreak [5].

Documented influenza risk factors include (i) individual demographic characteristics such as age (younger people have a higher risk of infection, while older people have a higher risk of complications and mortality), immunodeficiency, pregnancy, respiratory diseases and chronic underlying medical conditions (ii) individual household characteristics such as living with children; and (iii) individual profession such as having contacts with children or infected people [6,7,8]. Co-morbidity with respiratory viruses including influenza A, cause varying degree of morbidity especially in TB patients compared to general population [9]. In particular, influenza can weaken innate immune responses to secondary bacterial infections by impairing the T cell immunity [10]. Increased mortality has been seen in TB patients following influenza infections [11]. Individuals with pulmonary tuberculosis (PTB) are at a higher risk of being infected with the influenza virus which may lead to chronic lung disease, immunosuppression and even death. A better understanding of the co-infection of influenza and TB is crucial for policymakers to prioritize the target population for influenza vaccination [12].

Thus, interventional prevention against influenza such as vaccination according to the recommendations by World Health Organization (WHO), could help to reduce influenza incidence, hospitalization and case fatality rates [13]. Personal protective measures, on the other hand, such as wearing a face mask, proper hand washing and cleanliness, and some other physical interventions, have shown to be beneficial in preventing disease transmission [14]. To properly target specific interventions, including PPE and vaccination, this study focused on identifying risk factors in TB patients with ILI. As only influenza A (H1N1)pdm09 was detected among patients with ILI, the necessity to determine the specific type of influenza virus associated with these risk factors before implementing interventions becomes crucial.

Our study seeks to bridge a critical gap in existing research by specifically investigating the risk factors associated with influenza among tuberculosis (TB) patients. While numerous studies have extensively explored risk factors for influenza in the general population, there remains an evident absence of comprehensive research focusing on TB patients. The current study aims to provide precise and detailed knowledge designed for TB patients, thereby advancing scientific understanding and informing targeted interventions for this neglected group. Therefore, current study identified the risk factors associated with influenza A (H1N1)pdm09 in TB patients with ILI who were admitted to and enrolled in a TB Directly Observed Therapy Program (DOTs) in tertiary care hospitals of Lahore.

Methods

Study design

A nested case-control study was conducted among Influenza A (H1N1)pdm09 positive TB cases with ILI and influenza A negative (H1N1)pdm09 TB controls with ILI.

Study population

A cohort of TB patients who were admitted to and enrolled in a TB Directly Observed Therapy Program (DOTs) in (Mayo Hospital and Infectious Disease Hospital) were followed for 12 weeks. TB patients who developed ILI and tested positive for influenza A (H1N1)pdm09 by conventional RT-PCR were chosen as cases, while those who tested negative by conventional RT-PCR were chosen as controls. Participants who refused to participate in this study were excluded. Mayo Hospital is one of the oldest and biggest hospitals in Lahore, Punjab. Infectious Disease hospital is specific for infectious diseases in which patients need isolation and specific treatments i.e. Rabies, TB. Mayo Hospital is a general hospital that deals with all kinds of diseases. Mayo and Infectious Disease hospitals were chosen due to their high admission rates for TB patients and accessibility, aiding data collection.

Study procedure

The data was gathered using a structured questionnaire. All participants who voluntarily agreed to participate in the nested case-control study were given a consent form in local language (Urdu). The sample size was determined based on a previously conducted cohort study, which initially included 152 TB patients as the main cohort [12]. Among these patients, 59 showed ILI symptoms. From those TB patients with ILI, 39 who tested positive for influenza A (H1N1)pdm09 were selected as cases, while the remaining 20 TB patients with ILI, but testing negative for influenza A (H1N1)pdm09, were chosen as controls. All TB patients were followed for a period of 12 weeks regardless of the influenza season. At the start of study period, to record influenza-like illness (ILI), a symptom card was provided to all the participants. Every participant was contacted once a week, in person. When the ILI symptoms were reported, a throat swab was taken for the detection of the influenza A (H1N1)pdm09 (Fig. 1). All cases and controls in the study were interviewed face-to-face in the local language (Urdu). All information about various risk factors (marital status, education, family type, public transportation use, smoking history, respiratory allergy, ventilation system, etc.) was collected on a predesigned questionnaire [15].

Fig. 1
figure 1

Flow chart of enrolled participants

Full size image

Laboratory procedure

An oropharyngeal swab was collected by a trained healthcare professional registered with the Pakistan Nursing Council within three days of the onset of symptoms. The sample was placed in a cryovial tube with 2–3 mL of viral transport media right away. All specimens were transported at 4 °C to the Disease Surveillance Laboratory, Department of Epidemiology & Public Health, University of Veterinary and Animal Sciences, Lahore, Pakistan. All samples were handled in a biosafety level 2 cabinets (BSL-2). The TRIzol Reagent ® was used to extract viral RNA according to the manufacturer’s instructions [16]. The RNA was either used immediately or stored at -80 °C for future use. Conventional RT-PCR was carried out on a 96-well (Applied Biosystems™ Veriti™ Thermal Cycler) machine using a Qiagen one-step RT-PCR kit following WHO instructions [17]. The reverse transcriptase step was performed at 50 °C for 30 min, 95 °C for 15 min, followed by 35 cycles of amplification (94 °C for 30 s, 55 °C (for M gene)/57°C (for HA gene) for 30 s, 72 °C for 20 s), 72 °C for 7 min, and held at 4 °C using the specific primers [17, 18] (Table 1). To detect the amplified product of RT-PCR, a 2% agarose gel was prepared. A gel documentation system was used to take a digital image of the gel (Supplementary Fig. 1).

Table 1 Primers [for M and (H1N1)pdm09] used in the study
Full size table

Statistical analysis

The datasets were entered into the EpiData software (version 3.1, Odense, Denmark), verified for errors and inconsistencies by randomly comparing digital data to paper files, and then exported to Excel (version 2013, Microsoft Office, USA) for further processing. For all statistical analyses, R software (version 4.2.1, R Foundation for Statistical Computing, Vienna, Austria) was used. Frequencies and proportions were used to quantify categorical variables. The symptom severity score was calculated using the subjective self-rating of eight symptoms, including a, cough, sore throat, runny nose, fatigue, fever, sneezing, headache, and muscle aches. Each symptom was scored on an ordinal scale, with responses ranging from absent (0) to mild (1), moderate (2), or severe (3) [19]. The association of independent risk factors with the desired outcome i.e. influenza A (H1N1)pdm09 positive and negative in TB patients with ILI was tested using univariable logistic regression analysis. Variables that fulfilled the selection criteria (i.e., p ≤ 0.25) were eligible for inclusion in multivariable logistic regression analysis [20]. The odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by using epiR package (version 2-0-60). Model fitness was determined using the likelihood ratio test and Akaike’s information criterion (AIC).

Results

From the main cohort of TB patients (n = 152) who were followed during the study period, 59 (39%) developed ILI symptoms; of them, 39 tested positive for influenza A (H1N1)pdm09, while 20 were detected negative for influenza A (H1N1)pdm09. Among TB patients with ILI, the ratio of males and females was almost equal. The majority was married and had a nuclear family. Details of demographical characteristics are described in (Table 2).

Table 2 Socio-demographic characteristics of TB Patients with ILI
Full size table

ILI was found in 39% (59/152) of the TB main cohort (95% CI: 31.44–46.75) of all enrolled participants (n = 152). About 66% (39/59) of the TB patients with ILI (95% CI: 53.37–76.86) tested positive for influenza A (H1N1)pdm09, while 34% (20/59) of the cases tested negative for influenza A (H1N1)pdm09 (Fig. 2).

Fig. 2
figure 2

Influenza A (H1N1)pdm09 among 59 TB patients with ILI

Full size image

Male TB patients with ILI were more likely to be infected with influenza A (H1N1), with ages ranging from 18 to 30 years (43.5%, 10/23) and 31 to 43 years (43.5%, 10/23) respectively (Fig. 3).

Fig. 3
figure 3

Distribution of Influenza A (H1N1)pdm09 positive and Influenza A (H1N1)pdm09 negative according to age and gender of TB patients with ILI

Full size image

Clinical characteristics

Among 59 TB patients with ILI, fatigue (95%) and sore throat (93%) were reported as the most common symptoms.. Muscle aches or body pain (86%), cough (80%), and fever (76%) were the other most common symptoms reported by the ILI group. Feeling feverish (58%), having a runny nose (58%), having a headache (42%), and sneezing (37%), were less frequently reported symptoms by the TB patients with ILI. shown in Fig. 4.

Fig. 4
figure 4

Distribution of clinical symptoms in ILI, Influenza A (H1N1)pdm09 positive cases and Influenza A (H1N1)pdm09 negative control group

Full size image

Most of the Influenza A (H1N1)pdm09 negative TB patients with ILI had mild symptoms such as sore throat, coughing, muscle or body aches, fever and fatigue (Table 3).

Table 3 Symptoms severity score among TB Patients with ILI
Full size table

The univariable analysis demonstrated three independent risk factors and one protective factor for influenza A (H1N1)pdm09 with p value ≤ 0.25 (selection criteria for building a multivariable model). The use of public transport (p = 0.002), sharing towels (p = 0.02), and a history of smoking (p = 0.002) showed strong positive associations with influenza A (H1N1)pdm09 infection. Wearing a face mask (p = < 0.001) was identified as a protective factors that showed a strong positive association with influenza A (H1N1)pdm09 infection prevention. (Table 4).

Table 4 Univariable analysis of potential risk factors associated with Influenza A (H1N1)pdm09 with p value ≤ 0.25 among TB patients with ILI
Full size table

The final model detected one risk factor (sharing of towels, p = 0.008) and one protective factor (wearing a face mask, p = < 0.001) for Influenza A (H1N1)pdm09, that was best fitted to the model (Table 5).

Table 5 Multivariable analysis of potential risk factors associated with Influenza A (H1N1)pdm09 with p value ≤  0.05 among TB patients with ILI
Full size table

Discussion

Individuals with pulmonary tuberculosis (PTB) are at higher risk for severe influenza virus infections and co-morbidity with respiratory viruses including influenza A, cause varying degree of morbidity especially in TB patients compared to general population [9, 21]. The identification and reduction of risk factors is most important in primary interventions for health promotion and maintenance [22]. To properly target specific interventions, including PPE and vaccination, the study focused on identifying risk factors associated with influenza positivity in TB patients with ILI. As only influenza A (H1N1)pdm09 was detected among TB patients with ILI, the necessity to determine the specific type of influenza virus associated with these risk factors before implementing interventions becomes crucial. Therefore, this study estimates the risk factors associated with influenza A (H1N1)pdm09 infection in tuberculosis patients. Univariable analysis indicated that individuals who used public transport had a 16 times higher risk of getting influenza infection compared to those who used their own transport. There is a possibility that transmission occurred among passengers due to their close proximity with an infected individual. The duration and frequency of travel may have increased the chances of flu transmission [23, 24]. Various earlier studies have demonstrated that using public transport increases the risk of viral transmission due to the correlation between recent use of public transport and the onset of influenza symptoms [15, 25]. Smoking was also found to be a risk factor in the current study. The results showed that smokers were 8.55 times more likely to be infected as compared to non-smokers. Previously, it was estimated that smokers werefive times more likely than non-smokers to develop laboratory-confirmed influenza [26]. Smoking increases the risk of respiratory diseases [27, 28]. It is also a well-identified risk factor for the development and progression of infectious diseases like influenza viruses [26, 29]. Smoking has been demonstrated to inhibit the response of lung T cells to influenza viruses, which increases susceptibility to infection [30]. Smoking increases the risk of infection and worsening of the disease (including increased mortality and duration of the disease), which is caused by exacerbating innate and adaptive inflammatory responses [28]. Another significant factor reported in current study was towel sharing (OR = 3.88), which was linked to the development of influenza. When towels and handkerchiefs are used to dry or wipe the face and hands, viruses can be transmitted from contaminated surfaces, increasing the risk of influenza and other respiratory infectious diseases. According to previous studies, sharing towels is a risk factor for outbreaks of respiratory infectious diseases [31, 32].

In this study, wearing a face mask was found to be a significant protective factor against transmission of influenza. The current findings have been supported by various earlier studies [33,34,35]. The use of masks not only protects healthy people, but also decreases the transmission during infectiousness period of asymptomatic and symptomatic carriers, reduction in the number and efficacy of transmission sources within the population. Second, it is expected that wearing a mask will influence behavior. Wearing a mask can increase awareness of the risk of infection as well as the importance of further preventive behaviors such as frequent hand washing, avoiding physical contact, and avoiding crowded public places. Finally, wearing a mask is the most effective way to prevent airborne transmission, which can result in most serious cases of influenza [36]. In this study, fatigue, cough, muscle aches and fever were the most common reported symptoms. Similarly, these symptoms have also reported in earlier studies of laboratory confirmed influenza cases [19, 20]. This study focused solely on influenza A (H1N1)pdm09 risk factors and did not further study any other respiratory pathogens. The identification of risk factors will guide to design interventions to reduce the burden of influenza co-infection among TB patients. Our study findings are also valuable for healthcare officials and policymakers/decision makers who are involved in influenza prevention and control programs. This study was part of a previous cohort study; thus, the sample size was not large enough, and the presence of a zero-cell value in 2 × 2 contingency tables, as a result, many factors were not studied.

Conclusion

The current study identified the risk factors of influenza A (H1N1)pdm09 infection among tuberculosis patients. Behavioral factors are associated with influenza transmission as well play a role in influenza prevention. Human behavior may contribute to the breakdown of the chain of infection. Modification of behavioral factors could lower the risk of influenza A (H1N1)pdm09 infection and can prevent the outbreaks among TB patients. Further study should be conducted for the more comprehensive picture.

Data availability

All data and material involved in the current study are available from the corresponding author on reasonable request.

References

  1. Feng L, Shay DK, Jiang Y, Zhou H, Chen X, Zheng Y, Jiang L, Zhang Q, Lin H, Wang S. Influenza-associated mortality in temperate and subtropical Chinese cities, 2003–2008. Bull World Health Organ. 2012;90(4):279–B288.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Earn DJ, Dushoff J, Levin SA. Ecology and evolution of the flu. Trends Ecol Evol. 2002;17(7):334–40.

    Article  Google Scholar 

  3. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11):1333–40.

    Article  CAS  PubMed  Google Scholar 

  4. Troeger CE, Blacker BF, Khalil IA, Zimsen SR, Albertson SB, Abate D, Abdela J, Adhikari TB, Aghayan SA, Agrawal S. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the global burden of Disease Study 2017. Lancet Respiratory Med. 2019;7(1):69–89.

    Article  Google Scholar 

  5. Bukhsh A, Rehman H, Mallhi TH, Ata H, Rehman IU, Lee L-H, Goh B-H, Khan TM. Parents’ attitude, awareness and behaviour towards influenza vaccination in Pakistan. Hum Vaccines Immunotherapeutics. 2018;14(4):952–7.

    Article  Google Scholar 

  6. Sappenfield E, Jamieson DJ, Kourtis AP. Pregnancy and susceptibility to infectious diseases. Infectious diseases in obstetrics and gynecology 2013, 2013.

  7. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med. 2009;361(20):1935–44.

    Article  CAS  PubMed  Google Scholar 

  8. Marchbanks TL, Bhattarai A, Fagan RP, Ostroff S, Sodha SV, Moll ME, Lee BY, Chang C-CH, Ennis B, Britz P. An outbreak of 2009 pandemic influenza A (H1N1) virus infection in an elementary school in Pennsylvania. Clin Infect Dis. 2011;52(suppl1):S154–60.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Mhimbira F, Hiza H, Mbuba E, Hella J, Kamwela L, Sasamalo M, Ticlla M, Said K, Mhalu G, Chiryamkubi M. Prevalence and clinical significance of respiratory viruses and bacteria detected in tuberculosis patients compared to household contact controls in Tanzania: a cohort study. Clin Microbiol Infect. 2019;25(1):107. e101-107. e107.

    Article  Google Scholar 

  10. Small C-L, Shaler CR, McCormick S, Jeyanathan M, Damjanovic D, Brown EG, Arck P, Jordana M, Kaushic C, Ashkar AA. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J Immunol. 2010;184(4):2048–56.

    Article  CAS  PubMed  Google Scholar 

  11. Noymer A. Testing the influenza–tuberculosis selective mortality hypothesis with Union Army data. Soc Sci Med. 2009;68(9):1599–608.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Umbreen G, Rehman A, Avais M, Jabeen C, Sadiq S, Maqsood R, Rashid HB, Afzal S, Chaudhry M. Burden of influenza A (H1N1) pdm09 infection among tuberculosis patients: a prospective cohort study. BMC Infect Dis. 2023;23(1):526.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Organization WH. WHO Strategic Advisory Group of experts on immunization: request for nominations. Wkly Epidemiol Record = Relevé épidémiologique Hebdomadaire. 2009;84(15):131–2.

    Google Scholar 

  14. Jefferson T, Foxlee R, Del Mar C, Dooley L, Ferroni E, Hewak B, Prabhala A, Nair S, Rivetti A. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ. 2008;336(7635):77–80.

    Article  PubMed  Google Scholar 

  15. Guerrisi C, Ecollan M, Souty C, Rossignol L, Turbelin C, Debin M, Goronflot T, Boëlle P-Y, Hanslik T, Colizza V. Factors associated with influenza-like-illness: a crowdsourced cohort study from 2012/13 to 2017/18. BMC Public Health. 2019;19:1–9.

    Article  Google Scholar 

  16. Rio DC, Ares M, Hannon GJ, Nilsen TW. Purification of RNA using TRIzol (TRI reagent). Cold Spring Harbor Protocols 2010, 2010(6):pdb. prot5439.

  17. Organization WH. CDC protocol of realtime RTPCR for swine influenza A (H1N1). CDC protocol of realtime RTPCR for swine influenza A (H1N1). edn.: World Health Organization (WHO); 2009.

  18. Kumar P, Kumar B, Gupta A, Sharma B, Vijayan V, Khare S, Singh V, Daga M, Chadha M, Mishra A. Diagnosis of novel pandemic influenza virus 2009 H1N1 in hospitalized patients. Indian J Virol. 2010;21:45–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. VanWormer JJ, Sundaram ME, Meece JK, Belongia EA. A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting. BMC Infect Dis. 2014;14(1):1–10.

    Article  Google Scholar 

  20. Hasan S, Iqbal M, Webby RJ, DeBeauchamp J, Rashid HB, Ahmad M-u-D, Nazir J, Sadiq S, Khan AW, Chaudhry M. Risk Factors of Influenza-Associated Respiratory Illnesses Reported to a Sentinel Hospital of Lahore, Pakistan: 2015–2016. Canadian Journal of Infectious Diseases and Medical Microbiology 2021, 2021.

  21. Huang H-Y, Lo C-Y, Chung F-T, Huang Y-T, Ko P-C, Lin C-W, Huang Y-C, Chung KF, Wang C-H. Risk factors for Influenza-Induced exacerbations and Mortality in Non-cystic Fibrosis Bronchiectasis. Viruses. 2023;15(2):537.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Pigeot I, De Henauw S, Foraita R, Jahn I, Ahrens W. Primary prevention from the epidemiology perspective: three examples from the practice. BMC Med Res Methodol. 2010;10(1):1–11.

    Article  Google Scholar 

  23. Sachun-Silva LS, Mejía CR. Use of public transport associated with colds in the capital of Peru: A cross-sectional study. 2021.

  24. Nasir ZA, Campos LC, Christie N, Colbeck I. Airborne biological hazards and urban transport infrastructure: current challenges and future directions. Environ Sci Pollut Res. 2016;23:15757–66.

    Article  Google Scholar 

  25. Zhen J, Chan C, Schoonees A, Apatu E, Thabane L, Young T. Transmission of respiratory viruses when using public ground transport: a rapid review to inform public health recommendations during the COVID-19 pandemic. South Afr Med J. 2020;110(6):478–83.

    CAS  Google Scholar 

  26. Lawrence H, Hunter A, Murray R, Lim W, McKeever T. Cigarette smoking and the occurrence of influenza–systematic review. J Infect. 2019;79(5):401–6.

    Article  CAS  PubMed  Google Scholar 

  27. Aronson MD, Weiss ST, Ben RL, Komaroff AL. Association between cigarette smoking and acute respiratory tract illness in young adults. JAMA. 1982;248(2):181–3.

    Article  CAS  PubMed  Google Scholar 

  28. Chavez J, Hai R. Effects of cigarette smoking on influenza Virus/Host interplay. Pathogens. 2021;10(12):1636.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Hanshaoworakul W, Simmerman JM, Narueponjirakul U, Sanasuttipun W, Shinde V, Kaewchana S, Areechokechai D, Levy J, Ungchusak K. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS ONE. 2009;4(6):e6051.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Feng Y, Kong Y, Barnes PF, Huang F-F, Klucar P, Wang X, Samten B, Sengupta M, Machona B, Donis R. Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infect Immun. 2011;79(1):229–37.

    Article  CAS  PubMed  Google Scholar 

  31. Wu S, Ma C, Yang Z, Yang P, Chu Y, Zhang H, Li H, Hua W, Tang Y, Li C. Hygiene behaviors associated with influenza-like illness among adults in Beijing, China: a large, population-based survey. PLoS ONE. 2016;11(2):e0148448.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Yuan J, Zhang L, Xu W, Shen J, Zhang P, Ma H. Reported changes in health-related behaviours in Chinese urban residents in response to an influenza pandemic. Epidemiol Infect. 2009;137(7):988–93.

    Article  CAS  PubMed  Google Scholar 

  33. Jefferson T, Del Mar CB, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, Van Driel ML, Jones MA, Thorning S, Beller EM. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Reviews 2020(11).

  34. Aiello AE, Murray GF, Perez V, Coulborn RM, Davis BM, Uddin M, Shay DK, Waterman SH, Monto AS. Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Dis. 2010;201(4):491–8.

    Article  PubMed  Google Scholar 

  35. Jefferson T, Del Mar C, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, Van Driel ML, Foxlee R, Rivetti A. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ 2009, 339.

  36. Brienen NC, Timen A, Wallinga J, Van Steenbergen JE, Teunis PF. The effect of mask use on the spread of influenza during a pandemic. Risk Analysis: Int J. 2010;30(8):1210–8.

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank all participants for giving data, as well as the hospital administration for granted access to all patients.

Funding

The Higher Education Commission (HEC) of Pakistan granted a Ph.D. studentship as part of the Indigenous 5000 Ph.D. phase II Fellowship Programme (Grant No. 520-139643-2MD6-26) to Gulshan Umbreen (first author) The National Research Program for Universities(NRPU), Higher Education Commission of Pakistan (Project No. 20-13742/NRPU/R&D/HEC/2020), also supported this research work. There were no funds available for the APC of currrent publication.

Author information

Authors and Affiliations

  1. Department of Epidemiology & Public Health, University of Veterinary and Animal Sciences, Lahore, Pakistan

    Gulshan Umbreen, Abdul Rehman, Chanda Jabeen, Muhammad Iqbal, Shakera Sadiq, Rubab Maqsood, Nimra Arshad, Muhammad Hassan Mushtaq & Mamoona Chaudhry

  2. Department of Veterinary Surgery, University of Veterinary and Animal Sciences, Lahore, Pakistan

    Sadaf Aslam & Hamad Bin Rashid

  3. Department of Patho-Biology, Faculty of Veterinary Animal Sciences, PMAS- Arid Agriculture University, Rawalpindi, Pakistan

    Aayesha Riaz

  4. Department of Community Medicine, King Edward Medical University, Lahore, Pakistan

    Saira Afzal

Authors
  1. Gulshan Umbreen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abdul Rehman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sadaf Aslam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chanda Jabeen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Muhammad Iqbal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Aayesha Riaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shakera Sadiq
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Rubab Maqsood
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hamad Bin Rashid
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Saira Afzal
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Nimra Arshad
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Muhammad Hassan Mushtaq
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Mamoona Chaudhry
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

M.C and G.U conception and designed the study. M.C, S.A, MHM and A.R, supervised the study. Implementation and data collection: GU, CJ, R.M, SA, MI, NA, AR and S.S. Statistical analysis and interpretation was performed by GU and MC. Critical review and editing by HBR, MC and GU. All authors approved the final manuscript and agreed for publication.

Corresponding author

Correspondence to Mamoona Chaudhry.

Ethics declarations

Ethics approval and consent to participate

This study followed the Declaration of Helsinki guidelines and was approved by the Institutional. Review Committee for Biomedical Research, University of Veterinary and Animal Sciences, Lahore, Pakistan (Letter no.127/IRC/BMR). Consent form was translated in to the local language (Urdu), which were easily understood by the participants. Informed consent was obtained from all participants or, if subjects were illiterates then from a legal guardian to collect data. All data analyzed during this study was kept confidential and anonymous. The data was coded and no identifying information was disclosed in this manuscript. Hence no consent for publication was required.

Consent for publication

This section was not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Umbreen, G., Rehman, A., Aslam, S. et al. Risk factors associated with influenza A (H1N1)pdm09: a nested case control study of TB patients with ILI in Lahore District, Pakistan. BMC Infect Dis 24, 741 (2024). https://doi.org/10.1186/s12879-024-09263-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-024-09263-7

Keywords

BMC Infectious Diseases

ISSN: 1471-2334

Contact us